Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HEALTHEQUITY, INC.HQY · Entity 3639 | Exec VP, Sales & Marketing | November 01, 2016 | November 03, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HEALTHEQUITY, INC.
Report date November 01, 2016 · Filed November 03, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100 |
Ending reported balance
After 2016-11-01 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2016-11-01 · Exercise / conversion · Acquired 2,500 · Balance 2,600 F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. Row 2 · 2016-11-01 · Exercise / conversion · Acquired 5,000 · Balance 7,600 F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. Row 3 · 2016-11-01 · Exercise / conversion · Acquired 5,000 · Balance 12,600 F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. Row 4 · 2016-11-01 · Exercise / conversion · Acquired 12,500 · Balance 25,100 F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. Row 5 · 2016-11-01 · Sale · Disposed 24,621 · Balance 479 F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.07 to $33.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Row 6 · 2016-11-01 · Sale · Disposed 379 · Balance 100 F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.18 to $33.36, inclusive. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.00 · Expires 2024-07-30 | Direct | 0 |
Reported balance
After 2016-11-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2016-11-01 · Exercise / conversion · Disposed 2,500 · Balance 0 F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F4: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.40 · Expires 2024-11-01 | Direct | 0 |
Reported balance
After 2016-11-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2016-11-01 · Exercise / conversion · Disposed 5,000 · Balance 0 F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F4: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.80 · Expires 2021-04-29 | Direct | 0 |
Reported balance
After 2016-11-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2016-11-01 · Exercise / conversion · Disposed 5,000 · Balance 0 F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F5: The options became exercisable in annual installments of 1,250 shares on April 29 in each of the years 2012, 2013, 2014 and 2015. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.40 · Expires 2024-11-01 | Direct | 37,500 |
Reported balance
After 2016-11-01 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2016-11-01 · Exercise / conversion · Disposed 12,500 · Balance 37,500 F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F6: The options became exercisable as to 12,500 shares on November 1, 2015, and as to 12,500 shares on November 1, 2016. The option becomes exercisable as to the remaining 25,000 shares in two annual installments of 12,500 on November 1, 2017 and 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.07 to $33.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.18 to $33.36, inclusive.
F4: The option is immediately exercisable.
F5: The options became exercisable in annual installments of 1,250 shares on April 29 in each of the years 2012, 2013, 2014 and 2015.
F6: The options became exercisable as to 12,500 shares on November 1, 2015, and as to 12,500 shares on November 1, 2016. The option becomes exercisable as to the remaining 25,000 shares in two annual installments of 12,500 on November 1, 2017 and 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2016 Filed Nov 3, 2016 19:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $20.40 | $0.00 |
DisclosureSEC source: 0001140361-16-084703 · doc1.xml · derivative · entry 10 Sydney Matthew · CIK 0001623681 · Exec VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 12,500 shares Expires 2024-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F6 · derivative.exercise_date: The options became exercisable as to 12,500 shares on November 1, 2015, and as to 12,500 shares on November 1, 2016. The option becomes exercisable as to the remaining 25,000 shares in two annual installments of 12,500 on November 1, 2017 and 2018. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 19:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001140361-16-084703 · doc1.xml · derivative · entry 9 Sydney Matthew · CIK 0001623681 · Exec VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F5 · derivative.exercise_date: The options became exercisable in annual installments of 1,250 shares on April 29 in each of the years 2012, 2013, 2014 and 2015. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 19:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $20.40 | $0.00 |
DisclosureSEC source: 0001140361-16-084703 · doc1.xml · derivative · entry 8 Sydney Matthew · CIK 0001623681 · Exec VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2024-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F4 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 19:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001140361-16-084703 · doc1.xml · derivative · entry 7 Sydney Matthew · CIK 0001623681 · Exec VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2024-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F4 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 19:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 379 | $33.27 | $12,607.44 |
DisclosureSEC source: 0001140361-16-084703 · doc1.xml · nonDerivative · entry 6 Sydney Matthew · CIK 0001623681 · Exec VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.18 to $33.36, inclusive. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 19:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 24,621 | $32.51 | $800,340.07 |
DisclosureSEC source: 0001140361-16-084703 · doc1.xml · nonDerivative · entry 5 Sydney Matthew · CIK 0001623681 · Exec VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479 F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.07 to $33.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 19:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $20.40 | $255,000.00 |
DisclosureSEC source: 0001140361-16-084703 · doc1.xml · nonDerivative · entry 4 Sydney Matthew · CIK 0001623681 · Exec VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 19:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 5,000 | $0.80 | $4,000.00 |
DisclosureSEC source: 0001140361-16-084703 · doc1.xml · nonDerivative · entry 3 Sydney Matthew · CIK 0001623681 · Exec VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 19:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 5,000 | $20.40 | $102,000.00 |
DisclosureSEC source: 0001140361-16-084703 · doc1.xml · nonDerivative · entry 2 Sydney Matthew · CIK 0001623681 · Exec VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. Read SEC document |
| November 01, 2016 Filed Nov 3, 2016 19:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 2,500 | $14.00 | $35,000.00 |
DisclosureSEC source: 0001140361-16-084703 · doc1.xml · nonDerivative · entry 1 Sydney Matthew · CIK 0001623681 · Exec VP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.